A new bill set to be considered on Wednesday by the House Ways & Means Committee would extend for two years telehealth flexibilities for Government-run Medicare enrollees that were adopted during the Covid-19 pandemic, and look to reform drug industry middlemen to pay for it.
At the end of the official public health emergency, Congress extended flexibilities that changed where and what kinds of care people could receive over telehealth, but those rules are set to expire at the end of the year. Telehealth use by Government-run Medicare enrollees remains above pre-pandemic levels for many specialities.
The health care industry has been anxious about what sorts of policies could be passed to help pay for the telehealth policies, which are broadly popular and bipartisan. The Ways & Means panel has attached policies that would regulate pharmacy benefit managers by limiting how they can receive money from drugmakers and imposing transparency requirements to the two-year telehealth extension.
Click this link for the original source of this article.
Author: Mario Aguilar and Rachel Cohrs Zhang
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.